Skip to main content
Erschienen in: Strahlentherapie und Onkologie 6/2013

01.06.2013 | Original article

A validated scoring system to identify long-term survivors after radiotherapy for metastatic spinal cord compression

verfasst von: D. Rades, M.D., T. Veninga, A. Bajrovic, J.H. Karstens, S.E. Schild

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to develop and validate a scoring system to identify long-term survivors after conventional radiotherapy (RT) for metastatic spinal cord compression (MSCC).

Patients and methods

Data from 1,125 patients who had received long-course RT for MSCC were included in this study. Of these patients, 344 survived for over 12 months and 781 died within a year following RT. Based on differences between the distributions of patient characteristics in the two groups, a scoring system was developed. Scores ranged from 0 to 18 points and 15 points was selected as the cutoff for identifying long-term survivors. Data from the 1,125 long-course RT patients (test group) were compared to data from 773 patients receiving short-course RT (validation group).

Results

A score of ≥ 15 points was associated with a 94 % proportion of long-term survivors. The 15-point cutoff resulted in a specificity of 98 % and a positive predictive value of 94 % for identification of long-term surviving patients. The proportions of long-term survivors for each scoring point in the validation group were very similar to those in the test group.

Conclusion

This new scoring system enabled identification of long-term survivors after RT for MSCC with very high specificity and positive predictive value. The score proved to be valid and reproducible.
Literatur
1.
Zurück zum Zitat Amdur RJ, Bennett J, Olivier K et al (2009) A Prospective, Phase II study demonstrating the potential value and limitation of radiosurgery for spine metastases. Am J Clin Oncol 32:515–520PubMedCrossRef Amdur RJ, Bennett J, Olivier K et al (2009) A Prospective, Phase II study demonstrating the potential value and limitation of radiosurgery for spine metastases. Am J Clin Oncol 32:515–520PubMedCrossRef
2.
Zurück zum Zitat Douglas S, Schild SE, Rades D (2012) Metastatic spinal cord compression in patients with cancer of unknown primary. Estimating the survival prognosis with a validated score. Strahlenther Onkol 188:1048–1051PubMedCrossRef Douglas S, Schild SE, Rades D (2012) Metastatic spinal cord compression in patients with cancer of unknown primary. Estimating the survival prognosis with a validated score. Strahlenther Onkol 188:1048–1051PubMedCrossRef
3.
Zurück zum Zitat Garg AK, Shiu AS, Yang J et al (2012) Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer 118:5069–5077PubMedCrossRef Garg AK, Shiu AS, Yang J et al (2012) Phase 1/2 trial of single-session stereotactic body radiotherapy for previously unirradiated spinal metastases. Cancer 118:5069–5077PubMedCrossRef
4.
Zurück zum Zitat Gerszten PC, Burton SA, Ozhasoglu C, Welch WC (2007) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine 32:193–199PubMedCrossRef Gerszten PC, Burton SA, Ozhasoglu C, Welch WC (2007) Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine 32:193–199PubMedCrossRef
5.
Zurück zum Zitat Gibbs IC, Kamnerdsupaphon P, Ryu MR et al (2007) Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol 82:185–190PubMedCrossRef Gibbs IC, Kamnerdsupaphon P, Ryu MR et al (2007) Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol 82:185–190PubMedCrossRef
6.
Zurück zum Zitat Lutz S, Berk L, Chang E et al (2011) Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 79:965–976PubMedCrossRef Lutz S, Berk L, Chang E et al (2011) Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 79:965–976PubMedCrossRef
7.
Zurück zum Zitat Martin AG, Cowley IR, Taylor BA et al (2012) (Stereotactic) radiosurgery XIX: spinal radiosurgery—2 year experience in a UK centre. Br J Neurosurg 26:53–58PubMedCrossRef Martin AG, Cowley IR, Taylor BA et al (2012) (Stereotactic) radiosurgery XIX: spinal radiosurgery—2 year experience in a UK centre. Br J Neurosurg 26:53–58PubMedCrossRef
8.
Zurück zum Zitat Nelson JW, Yoo DS, Sampson JH et al (2009) Stereotactic body radiotherapy for lesions of the spine and paraspinal regions. Int J Radiat Oncol Biol Phys 73:1369–1375PubMedCrossRef Nelson JW, Yoo DS, Sampson JH et al (2009) Stereotactic body radiotherapy for lesions of the spine and paraspinal regions. Int J Radiat Oncol Biol Phys 73:1369–1375PubMedCrossRef
9.
Zurück zum Zitat Patchell R, Tibbs PA, Regine WF et al (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366:643–648PubMedCrossRef Patchell R, Tibbs PA, Regine WF et al (2005) Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366:643–648PubMedCrossRef
10.
Zurück zum Zitat Rades D, Douglas S, Veninga T et al (2010) Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression. Cancer 116:3670–3673PubMedCrossRef Rades D, Douglas S, Veninga T et al (2010) Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression. Cancer 116:3670–3673PubMedCrossRef
11.
Zurück zum Zitat Rades D, Douglas S, Veninga T et al (2012) Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients. Strahlenther Onkol 188:472–476PubMedCrossRef Rades D, Douglas S, Veninga T et al (2012) Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients. Strahlenther Onkol 188:472–476PubMedCrossRef
12.
Zurück zum Zitat Rades D, Fehlauer F, Schulte R et al (2006) Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 24:3388–3393PubMedCrossRef Rades D, Fehlauer F, Schulte R et al (2006) Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. J Clin Oncol 24:3388–3393PubMedCrossRef
13.
Zurück zum Zitat Rades D, Huttenlocher S, Bajrovic A et al (2011) Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. Int J Radiat Oncol Biol Phys 81:e861–e868PubMedCrossRef Rades D, Huttenlocher S, Bajrovic A et al (2011) Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. Int J Radiat Oncol Biol Phys 81:e861–e868PubMedCrossRef
14.
Zurück zum Zitat Rades D, Huttenlocher S, Dunst J et al (2010) Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. J Clin Oncol 28:3597–3604PubMedCrossRef Rades D, Huttenlocher S, Dunst J et al (2010) Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. J Clin Oncol 28:3597–3604PubMedCrossRef
15.
Zurück zum Zitat Rades D, Veninga T, Stalpers LJ et al (2007) Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases. J Clin Oncol 25:50–56PubMedCrossRef Rades D, Veninga T, Stalpers LJ et al (2007) Outcome after radiotherapy alone for metastatic spinal cord compression in patients with oligometastases. J Clin Oncol 25:50–56PubMedCrossRef
16.
Zurück zum Zitat Rose PS, Laufer I, Boland PJ et al (2009) Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol 27:5075–5079PubMedCrossRef Rose PS, Laufer I, Boland PJ et al (2009) Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol 27:5075–5079PubMedCrossRef
17.
Zurück zum Zitat Ryu S, Jin R, Jin JY et al (2008) Pain control by image-guided radiosurgery for solitary spinal metastasis. J Pain Symptom Manage 35:292–298PubMedCrossRef Ryu S, Jin R, Jin JY et al (2008) Pain control by image-guided radiosurgery for solitary spinal metastasis. J Pain Symptom Manage 35:292–298PubMedCrossRef
18.
Zurück zum Zitat Ryu S, Rock J, Jain R et al (2010) Radiosurgical decompression of metastatic epidural compression. Cancer 116:2250–2257PubMed Ryu S, Rock J, Jain R et al (2010) Radiosurgical decompression of metastatic epidural compression. Cancer 116:2250–2257PubMed
19.
Zurück zum Zitat Tsai JT, Lin JW, Chiu WT, Chu WC (2009) Assessment of image-guided CyberKnife radiosurgery for metastatic spine tumors. J Neurooncol 94:119–127PubMedCrossRef Tsai JT, Lin JW, Chiu WT, Chu WC (2009) Assessment of image-guided CyberKnife radiosurgery for metastatic spine tumors. J Neurooncol 94:119–127PubMedCrossRef
Metadaten
Titel
A validated scoring system to identify long-term survivors after radiotherapy for metastatic spinal cord compression
verfasst von
D. Rades, M.D.
T. Veninga
A. Bajrovic
J.H. Karstens
S.E. Schild
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 6/2013
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-013-0342-1

Weitere Artikel der Ausgabe 6/2013

Strahlentherapie und Onkologie 6/2013 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.